Triangulate Labs Secures $1.62M Seed Funding to Transform Telemedicine with Skinmap™—Pioneering the Future of Diagnostics

Triangulate Labs is proud to announce a significant funding milestone, having successfully raised $1,620,000 to propel the future of diagnostics with its groundbreaking Skinmap™ technology. As a pioneer in telemedicine innovation, Triangulate Labs has developed Skinmap™, a patented Total Body Photography (TBP) system that revolutionizes the way doctors and patients interact remotely. By leveraging readily available iOS devices, Skinmap™ provides an affordable, accessible, and highly accurate method for tracking skin evolution, empowering AI-driven diagnostics, and aiding in the early detection of potential disease-related changes. This advancement is especially crucial in the fight against skin cancer, given that a person succumbs to the disease every five minutes, and the five-year survival rate for late-stage melanoma is alarmingly low at 30%. With early identification being a key factor in improving patient outcomes, Skinmap™ is positioned to transform how dermatologists recognize skin cancer and other dangerous lesions by meticulously documenting changes over time. The new funding will accelerate the ongoing development and broader deployment of Skinmap™, enabling further clinical research, refinement of AI algorithms, and expansion of telehealth services. Triangulate Labs is committed to addressing a critical healthcare need by making early cancer detection more accessible, potentially saving countless lives. By seamlessly integrating innovative digital imaging with sophisticated diagnostic analytics, the company is set to lead a global shift in preventive care. This announcement marks a significant step forward in transforming dermatological diagnostics, empowering healthcare providers, and ultimately, contributing to a future where the early detection of skin cancer is the norm rather than the exception.